Solanum torvum inhibits Helicobacter pylori growth and mediates apoptosis in human gastric epithelial cells

Oncology Reports

Volumn 23, Issue 5, 2010, Pages 1401-1405

  Hsu, Yuan Man ^a   Weng, Jing Ru ^a   Huang, Tsurng Juhn ^b   Lai, Chih Ho ^a   Su, Chiu Hsiang ^a   Chou, Chang Hung ^b  

^a CHINA MEDICAL UNIVERSITY   (Taiwan)

^b CHINA MEDICAL UNIVERSITY   (Taiwan)

Author keywords

Apoptosis; Helicobacter pylori; Human gastric epithelial cells; Solanum torvum

Indexed keywords

ACETONE; ANTIBIOTIC AGENT; ANTIINFECTIVE AGENT; CHLOROFORM; CLARITHROMYCIN; LANSOPRAZOLE; METHANOL; METRONIDAZOLE; PLANT EXTRACT; SOLANUM ERIANTHUM EXTRACT; SOLANUM TORVUM EXTRACT; UNCLASSIFIED DRUG; WATER;

ANTIBACTERIAL ACTIVITY; ANTIBIOTIC RESISTANCE; ANTIMICROBIAL ACTIVITY; APOPTOSIS; ARTICLE; BACTERIAL GROWTH; COMPARATIVE STUDY; CONTROLLED STUDY; EPITHELIUM CELL; GROWTH INHIBITION; HELICOBACTER INFECTION; HELICOBACTER PYLORI; HOST CELL; HUMAN; HUMAN CELL; MEDICINAL PLANT; MULTIDRUG RESISTANCE; NONHUMAN; PRIORITY JOURNAL; SOLANUM; SOLANUM ERIANTHUM; SOLANUM TORVUM; STOMACH EPITHELIUM; STOMACH INJURY;

EID: 77950853350     PISSN: 1021335X     EISSN: 17912431     Source Type: Journal    
DOI: 10.3892/or_00000777     Document Type: Article

References (31)

1. Kusters JG, van Vliet AH and Kuipers EJ: Pathogenesis of Helicobacter pylori infection. Clin Microbiol Rev 19: 449-490, 2006.
2. Amieva MR and El-Omar EM: Host-bacterial interactions in Helicobacter pylori infection. Gastroenterology 134: 306-323, 2008.
3. Peek RM Jr and Blaser MJ: Helicobacter pylori and gastrointestinal tract adenocarcinomas. Nat Rev Cancer 2: 28-37, 2002.
4. Correa P: The biological model of gastric carcinogenesis: IARC Sci Publ 157: 301-310, 2004.
5. Gao LY and Kwaik YA: The modulation of host cell apoptosis by intracellular bacterial pathogens. Trends Microbiol 8: 306-313, 2000.
6. Xia HH and Talley NJ: Apoptosis in gastric epithelium induced by Helicobacter pylori infection: implications in gastric carcinogenesis. Am J Gastroenterol 96: 16-26, 2001.
7. Piotrowski J, Skrodzka D, Slomiany A and Slomiany BL: Helicobacter pylori lipopolysaccharide induces gastric epithelial cells apoptosis. Biochem Mol Biol Int 40: 597-602, 1996.
8. Moss SF, Calam J, Agarwal B, Wang S and Holt PR: Induction of gastric epithelial apoptosis by Helicobacter pylori. Gut 38: 498-501, 1996.
9. Bartchewsky W Jr, Martini MR, Squassoni AC, et al: Effects of Helicobacter pylori infection on the expressions of Bax and Bcl-2 in patients with chronic gastritis and gastric cancer. Dig Dis Sci (In press).
10. Maeda S, Yoshida H, Mitsuno Y, et al: Analysis of apoptotic and antiapoptotic signalling pathways induced by Helicobacter pylori. Mol Pathol 55: 286-293, 2002. (Pubitemid 35193253)
11. Ashktorab H, Dashwood RH, Dashwood MM, et al: H. pyloriinduced apoptosis in human gastric cancer cells mediated via the release of apoptosis-inducing factor from mitochondria. Helicobacter 13: 506-517, 2008.
12. Ables AZ, Simon I and Melton ER: Update on Helicobacter pylori treatment. Am Fam Physician 75: 351-358, 2007.
13. Egan BJ, Marzio L, O'Connor H and O'Morain C: Treatment of Helicobacter pylori infection. Helicobacter 13 (Suppl 1): 35-40, 2008.
14. Lee MR: The Solanaceae: foods and poisons. J R Coll Physicians Edinb 36: 162-169, 2006.
15. Kupchan SM, Barboutis SJ, Knox JR and Cam CA: Betasolamarine: tumor inhibitor isolated from Solanum dulcamara. Science 150: 1827-1828, 1965.
16. Cham BE, Gilliver M and Wilson L: Antitumour effects of glycoalkaloids isolated from Solanum sodomaeum. Planta Med 53: 34-36, 1987.
17. Hu K, Kobayashi H, Dong A, Jing Y, Iwasaki S and Yao X: Antineoplastic agents. III: steroidal glycosides from Solanum nigrum. Planta Med 65: 35-38, 1999.
18. Kuo KW, Hsu SH, Li YP, et al: Anticancer activity evaluation of the solanum glycoalkaloid solamargine. Triggering apoptosis in human hepatoma cells. Biochem Pharmacol 60: 1865-1873, 2000.
19. McKay DL and Blumberg JB: A review of the bioactivity and potential health benefits of peppermint tea (Mentha piperita L.). Phytother Res 20: 619-633, 2006.
20. McKay DL and Blumberg JB: A review of the bioactivity and potential health benefits of chamomile tea (Matricaria recutita L.). Phytother Res 20: 519-530, 2006.
21. Sengupta A, Ghosh S and Bhattacharjee S: Allium vegetables in cancer prevention: an overview. Asian Pac J Cancer Prev 5: 237-245, 2004.
22. Odontuya G, Hoult JR and Houghton PJ: Structure-activity relationship for antiinflammatory effect of luteolin and its derived glycosides. Phytother Res 19: 782-786, 2005.
23. Gang DR: Evolution of flavors and scents. Annu Rev Plant Biol 56: 301-325, 2005.
24. Stone MJ and Williams DH: On the evolution of functional secondary metabolites (natural products). Mol Microbiol 6: 29-34, 1992.
25. Williams DH, Stone MJ, Hauck PR and Rahman SK: Why are secondary metabolites (natural products) biosynthesized? J Nat Prod 52: 1189-1208, 1989.
26. De Marino S, Borbone N, Gala F, et al: New constituents of sweet Capsicum annuum L. fruits and evaluation of their biological activity. J Agric Food Chem 54: 7508-7516, 2006.
27. Zhou LX and Ding Y: A cinnamide derivative from Solanum verbascifolium L. J Asian Nat Prod Res 4: 185-187, 2002.
28. Chah KF, Muko KN and Oboegbulem SI: Antimicrobial activity of methanolic extract of Solanum torvum fruit. Fitoterapia 71: 187-189, 2000.
29. Poon SK, Chang CS, Su J, et al: Primary resistance to antibiotics and its clinical impact on the efficacy of Helicobacter pylori lansoprazole-based triple therapies. Aliment Pharmacol Ther 16: 291-296, 2002.
30. Lai CH, Kuo CH, Chen PY, Poon SK, Chang CS and Wang WC: Association of antibiotic resistance and higher internalization activity in resistant Helicobacter pylori isolates. J Antimicrob Chemother 57: 466-471, 2006.
31. Cavallaro LG, Egan B, O'Morain C and Di Mario F: Treatment of Helicobacter pylori infection. Helicobacter 11 (Suppl 1): 36-39, 2006.